Home/Filings/4/0001127602-23-017879
4//SEC Filing

Gryaznov Sergei 4

Accession 0001127602-23-017879

CIK 0001878313other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 5:17 PM ET

Size

5.1 KB

Accession

0001127602-23-017879

Insider Transaction Report

Form 4
Period: 2023-05-31
Gryaznov Sergei
Chief Scientific Officer
Transactions
  • Award

    Stock Options

    2023-05-31+75,98275,982 total
    Exercise: $2.50From: 2023-05-31Exp: 2032-05-30Common Stock (75,982 underlying)
Footnotes (1)
  • [F1]The stock options, granted on May 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0001913228

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:17 PM ET
Size
5.1 KB